Bristol-Myers Squibb (BMY) Announces FDA Accepts its Application for Opdivo Plus Yervoy in Intermediate- and Poor-Risk Patients with Advanced RCC and Grants Priority Review
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has accepted its supplemental Biologics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
